Aldosterone (Aldo) through Mineralcorticoid Receptor (MR) plays an important pathophysiological role in cardiovascular remodeling and diseases. Cardiac remodeling is characterized by changes in the extracellular matrix (ECM), which favors the development of myocardial fibrosis, and finally could compromises cardiac function and contributes to heart failure. Neutrophil gelatinase-associated lipocalin (NGAL) is a primary target of Aldosterone (Aldo)/MR in the cardiovascular system. However, the role of NGAL in cardiac remodeling is still unclear. We investigated the effects of NGAL on the production of ECM components in human cardiac fibroblasts (HCF) and whether NGAL could be a mediator of Aldo-induced ECM components in HCF. Collagen I protein levels were measured in response to Aldo (10- 10-10-8M) and NGAL (5-500 ng/ml) in HCF for 12-24 hours. Protein and gene expression of different profibrotic mediators such as galectin-3 (Gal-3), cardiotrophin-1 (CT-1), transforming growth factor-beta (TGF-β) and metalloproteinase (MMP) activities were studied in response to NGAL and Aldo. Finally, in order to study the role of NGAL on the profibrotic actions of Aldo, NGAL-silenced HCF were treated with Aldo In HCF, Aldo and NGAL increased collagen I protein expression in a dose-dependent manner, reaching maximal values at 24 hours. At this time, Aldo increased NGAL protein expression. NGAL and Aldo enhanced profibrotic mediators such as Gal-3, CT-1 and TGF-β, as well as MMP-1, MMP-2 and MMP-9 activities. In NGAL silenced cells, Aldo was not able to modify collagen I expression as well as fibronectin, galectin-3, cardiotrophin- 1 and TGF-β levels. Our results indicated that NGAL exerts profibrotic effects in HCF. Furthermore, NGAL emerges as a potential mediator of Aldo-induced cardiac fibrosis and could be consider as a biotarget for novel pharmacological approaches, especially in diseases where Aldo/MR pathway is involved. The author hereby declares no conflict of interest
Read full abstract